Francis Akpa-Inyang | Public Health | Young Scientist Award

Published on by Young Scientists Awards

Dr. Francis Akpa-Inyang | Public Health | Young Scientist Award

Research Associate | Durban University of Technology | South Africa

Dr. Francis Akpa-Inyang is a multidisciplinary public health scholar whose research integrates bioethics, indigenous knowledge systems, research integrity, and applied health sciences. His work advances understanding of informed consent within African traditional medicine, exploring how cultural values, communal decision-making, and indigenous ethical frameworks shape patient autonomy and healthcare interactions. He has developed a pluralistic model for healthcare decision-making that offers a culturally grounded alternative to Western biomedical ethics, contributing significantly to debates on ethics in global health. His scholarship further extends to orthopaedic research, 3D-printing innovation, public health behaviour, infectious disease knowledge, and higher-education teaching and learning. He has published widely in peer-reviewed journals, addressing themes such as ethical regulation, cross-cultural consent processes, infection control, ergonomics in remote work, pedagogy, and health-seeking behaviours. In addition to his academic contributions, he plays an active role in strengthening research integrity systems in Africa, drafting institutional policies, investigating ethical breaches, and providing training in responsible research conduct. He collaborates with multidisciplinary teams, contributes to international conferences, and supports emerging scholars through supervision and mentorship across public health, clinical sciences, and social science research. His work on ethical, legal, social, and cultural issues in emerging technologies, including synthetic biology and artificial intelligence, reinforces his commitment to ethical governance in rapidly evolving scientific landscapes. With expertise spanning bioethics, public health research, academic development, and research integrity leadership, he is recognized for advancing culturally responsive ethical practices and promoting high standards of scientific conduct within African and global research environments.

Featured Publication

Akpa-Inyang, F. (2025). The San Code of Ethics versus international ethical guidelines: A cross-cultural analysis. African Journal of Inter/Multidisciplinary Studies, 7(1).

Awais ALi | vaccine | Young Scientist Award

Published on by Young Scientists Awards

Dr. Awais ALi | vaccine | Young Scientist Award

RESEARCHER  at COMPUTATIONAL GENOMICS , Pakistan

Awais Ali (b. 30 Nov 2000) is a Pakistani researcher specializing in computational genomics and medicinal plant transcriptomics. He holds a BS in Biochemistry from Abdul Wali Khan University, focusing on secondary metabolite characterization. With expertise in bioinformatics tools, Linux-based commands, and databases like KEGG, MetaCyc, and DAVID, he has contributed to mutational screening, hepatotoxicity studies, and metabolomic research. Awais has presented at the 2nd International Conference on Drug Discovery & Development and has certifications in digital marketing and freelancing. His research is published in Scopus and WoS-indexed journals, reflecting his contributions to molecular biology and bioinformatics. 📊🔬📚

Publication Profile

Orcid

🎓 Academic Background of Awais Ali

Awais Ali holds a BS in Biochemistry (2018–2022) from Abdul Wali Khan University, Mardan, with a 3.2 GPA (A grade). His thesis focused on the transcriptome analysis of Artemisia Argyi for secondary metabolite characterization. He also earned a Diploma in Information Technology (2020–2021) from Government Technical Vocational College. Awais has further enhanced his skills through certifications in Digital Marketing and Freelancing from DigiSkills Pakistan. Proficient in bioinformatics tools, he specializes in KEGG, MetaCyc, DAVID, and R programming. He participated in the 2nd International Conference on Advances in Drug Discovery & Development (2022), showcasing his expertise in genomics and transcriptomics. 🔬📊💻

Professional Background

Awais Ali has extensive experience in computational research and database management. From 2020 to 2022, he worked as a Database Manager, collecting medicinal compounds from literature and scripting databases. Since 2019, he has been actively involved in computational genomics research, utilizing various bioinformatics tools and Linux-based commands for filtration, assembling, alignment, and BLAST analysis. He specializes in working with databases such as KEGG, MetaCyc, PlantCyc, MetaboAnalyst, DAVID, GO3, Panther, and Plant Reactomics. His expertise lies in data processing, genomic analysis, and bioinformatics workflows, contributing significantly to computational biology. 🔬💻📊

🔬 Research Focus

This researcher specializes in computational genomics, bioinformatics, and medicinal plant transcriptomics. Their work includes mutational screening, secondary metabolite characterization, and drug-induced toxicity studies. They utilize Linux, Ubuntu, UNIX, MS-DOS, and Windows for data analysis, sequence alignment, BLAST, and enrichment analysis. Their research spans medicinal plant bioactives, genetic disorders like CMT disease, and hepatotoxicity studies. Their published work in Scopus and WoS-indexed journals reflects their contributions to genome analysis, metabolic pathways, and pharmacological research, making them a key figure in computational biology and molecular medicine. 🧬💻🌿

Publication Top Notes

1️⃣ Identification and assessment of hub genes and miRNAs coregulatory associated with immune infiltrations and drug interactions in latent tuberculosis 🧬💊
Year: 2025 | Journal: Biochemistry and Biophysics Reports

2️⃣ Multi-epitope-based vaccine models prioritization against Astrovirus MLB1 using immunoinformatics and reverse vaccinology approaches 💉🔬
Year: 2025 | Journal: Journal of Genetic Engineering and Biotechnology

3️⃣ Design, synthesis, characterization and biological screening of novel thiosemicarbazones and their derivatives with potent antibacterial and antidiabetic activities 🦠⚕️
Year: 2025 | Journal: Journal of Molecular Structure

4️⃣ Promising vaccine models against astrovirus MLB2 using integrated vaccinomics and immunoinformatics approaches 💉🧪
Year: 2024 |  Journal: Molecular Systems Design & Engineering

5️⃣ NK/DC crosstalk-modulating antitumor activity via Sema3E/PlexinD1 axis for enhanced cancer immunotherapy 🎗️🦠
Year: 2024 | Journal: Immunologic Research